An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

(2011) Suleiman Massarweh et al.   BREAST CANCER RESEARCH AND TREATMENT

Mechanisms of Endocrine Resistance in Breast Cancer

(2010) C. Kent Osborne et al.   Annual Review of Medicine

MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells

(2010) Lu Jiang et al.   BIOCHEMICAL JOURNAL

MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways

(2010) X Rao et al.   ONCOGENE

Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer

(2009) M. D. Green et al.   ANNALS OF ONCOLOGY

Widespread Estrogen-Dependent Repression of microRNAs Involved in Breast Tumor Cell Growth

(2009) G. Maillot et al.   CANCER RESEARCH

Estradiol-regulated microRNAs control estradiol response in breast cancer cells

(2009) Poornima Bhat-Nakshatri et al.   NUCLEIC ACIDS RESEARCH

Prediction of hormone sensitivity for breast cancers

(2009) Yasuo Miyoshi et al.   Breast Cancer

microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma

(2008) B. Kefas et al.   CANCER RESEARCH

MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer

(2008) Jian-Jun Zhao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

RETRACTED: The Expression and Ovarian Steroid Regulation of Endometrial Micro-RNAs

(2008) Tannaz Toloubeydokhti et al.   Reproductive Sciences